Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
Journal of the National Cancer Institute
|
March 23, 2013
Response
Julien Péron, Benoit You
Statistical Methods in Medical Research
|
October 11, 2021
The asymptotic distribution of the Net Benefit estimator in presence of right-censoring
Brice Ozenne, Esben Budtz-Jørgensen, Julien Péron
Annals of Surgical Oncology
|
October 27, 2021
ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection
Vahan Kepenekian, Julien Péron, Benoit You, et al.
Pancreas
|
January 11, 2019
The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma
Julien Péron, Joris Giai, Delphine Maucort-Boulch, et al.
Journal of Paediatrics and Child Health
|
April 9, 2019
Re: Everything is awesome: Don't forget the lego
Teresa de Rojas, Anouk Neven, Sarah Kelly, et al.
PLOS Global Public Health
|
September 25, 2023
What went right during the COVID crisis: The capabilities of local actors and lasting innovations in oncology care and research
Brenda Bogaert, Zisis Kozlakidis, Elodie Caboux, et al.
PLOS Global Public Health
|
October 31, 2024
Correction: What went right during the COVID crisis: The capabilities of local actors and lasting innovations in oncology care and research
Brenda Bogaert, Zisis Kozlakidis, Elodie Caboux, et al.
JAMA Oncology
|
April 29, 2016
The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials
Julien Péron, Pascal Roy, Brice Ozenne, et al.
The Oncologist
|
May 18, 2018
Meta-Research on Oncology Trials: A Toolkit for Researchers with Limited Resources
Rachel P Riechelmann, Julien Péron, Bostjan Seruga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2014
Prognosis of t1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas
Luc Cabel, Julien Péron, Paul Henri Cottu, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
Journal of the National Cancer Institute
|
March 23, 2013
Response
Julien Péron, Benoit You
Statistical Methods in Medical Research
|
October 11, 2021
The asymptotic distribution of the Net Benefit estimator in presence of right-censoring
Brice Ozenne, Esben Budtz-Jørgensen, Julien Péron
Annals of Surgical Oncology
|
October 27, 2021
ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection
Vahan Kepenekian, Julien Péron, Benoit You, et al.
Pancreas
|
January 11, 2019
The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma
Julien Péron, Joris Giai, Delphine Maucort-Boulch, et al.
Journal of Paediatrics and Child Health
|
April 9, 2019
Re: Everything is awesome: Don't forget the lego
Teresa de Rojas, Anouk Neven, Sarah Kelly, et al.
PLOS Global Public Health
|
September 25, 2023
What went right during the COVID crisis: The capabilities of local actors and lasting innovations in oncology care and research
Brenda Bogaert, Zisis Kozlakidis, Elodie Caboux, et al.
PLOS Global Public Health
|
October 31, 2024
Correction: What went right during the COVID crisis: The capabilities of local actors and lasting innovations in oncology care and research
Brenda Bogaert, Zisis Kozlakidis, Elodie Caboux, et al.
JAMA Oncology
|
April 29, 2016
The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials
Julien Péron, Pascal Roy, Brice Ozenne, et al.
The Oncologist
|
May 18, 2018
Meta-Research on Oncology Trials: A Toolkit for Researchers with Limited Resources
Rachel P Riechelmann, Julien Péron, Bostjan Seruga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2014
Prognosis of t1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas
Luc Cabel, Julien Péron, Paul Henri Cottu, et al.
Page
of 9